Surgery for Borderline Resectable Pancreatic Ductal Adenocarcinoma Preoperative Planning, Technical Considerations, and Building a Program

被引：0
|
作者：
Drake, Justin [1 ]
Anaya, Daniel A. [1 ,2 ]
Fleming, Jason B. [1 ,3 ]
Denbo, Jason W. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA
[2] UT Southwestern Med Ctr, Div GI Surg, Dallas, TX USA
[3] UT Southwestern Med Ctr, Dept Surg, Dallas, TX USA
来源：
SURGICAL CLINICS OF NORTH AMERICA | 2024年 / 104卷 / 05期
关键词：
Ancreaticoduodenectomy; Periampullary region; Oncologic therapy; Pancreatic surgery; CONSENSUS STATEMENT; CANCER; PANCREATICODUODENECTOMY; CARCINOMA; AMPULLA;
D O I：
10.1016/j.suc.2024.07.001
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1031 / 1048
页数：18
相关论文
共 50 条
  • [31] Patient outcome according to the 2017 international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma
    Medrano, J.
    Garnier, J.
    Ewald, J.
    Marchese, U.
    Gilabert, M.
    Launay, S.
    Poizat, F.
    Giovannini, M.
    Delpero, J. R.
    Turrini, O.
    PANCREATOLOGY, 2020, 20 (02) : 223 - 228
  • [32] Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma
    Schwarz, Lilian
    Katz, Matthew Harold G.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (04) : 727 - +
  • [33] The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice?
    Zerbi, Alessandro
    Nappo, Gennaro
    ENDOSCOPIC ULTRASOUND, 2017, 6 : S87 - S89
  • [34] Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma
    Tinchon, Christoph
    Hubmann, Eva
    Pichler, Angelika
    Keil, Felix
    Pichler, Martin
    Rabl, Hans
    Uggowitzer, Martin
    Jilek, Kurt
    Leitner, Gerhard
    Bauernhofer, Thomas
    ACTA ONCOLOGICA, 2013, 52 (06) : 1231 - 1234
  • [35] Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population
    Walpole, Imogen
    Lee, Belinda
    Shapiro, Jeremy
    Thomson, Benjamin
    Lipton, Lara
    Ananda, Sumitra
    Usatoff, Val
    Mclachlan, Sue-Ann
    Knowles, Brett
    Fox, Adrian
    Wong, Rachel
    Cooray, Prasad
    Burge, Matthew
    Clarke, Kate
    Pattison, Sharon
    Nikfarjam, Mehrdad
    Tebbutt, Niall
    Harris, Marion
    Nagrial, Adnan
    Zielinski, Rob
    Chee, Cheng Ean
    Gibbs, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (01) : 214 - 225
  • [36] Surgery for recurrent pancreatic ductal adenocarcinoma
    Kleeff, Joerg
    Reiser, Carolin
    Hinz, Ulf
    Bachmann, Jeannine
    Debus, Jurgen
    Jaeger, Dirk
    Friess, Helmut
    Buechler, Markus W.
    ANNALS OF SURGERY, 2007, 245 (04) : 566 - 572
  • [37] Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios
    Asari, Sadaki
    Matsumoto, Ippei
    Toyama, Hirochika
    Shinzeki, Makoto
    Goto, Tadahiro
    Ishida, Jun
    Ajiki, Tetsuo
    Fukumoto, Takumi
    Ku, Yonson
    SURGERY TODAY, 2016, 46 (05) : 583 - 592
  • [38] Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Chandana, Sreenivasa
    Eastburg, Benjamin
    Frisch, Austin
    Parker, Jessica
    Wright, G. Paul
    Assifi, M. Mura
    Chung, Mathew
    AMERICAN SURGEON, 2024, 90 (11) : 2762 - 2768
  • [39] Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma
    Xie, Hao
    Liu, Junjia
    Yin, Jun
    Ogden, John R.
    Mahipal, Amit
    McWilliams, Robert R.
    Truty, Mark J.
    Bekaii-Saab, Tanios S.
    Petersen, Gloria M.
    Jatoi, Aminah
    Hubbard, Joleen M.
    Ma, Wen Wee
    ONCOLOGIST, 2020, 25 (11) : E1681 - E1690
  • [40] Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery
    Terlizzi, Mario
    Buscail, Etienne
    Boussari, Olayide
    Adgie, Sarah
    Leduc, Nicolas
    Terrebonne, Eric
    Smith, Denis
    Blanc, Jean-Frederic
    Lapuyade, Bruno
    Laurent, Christophe
    Chiche, Laurence
    Belleannee, Genevieve
    Le Malicot, Karine
    Trouette, Renaud
    Pouypoudat, Claudia
    Vendrely, Veronique
    ACTA ONCOLOGICA, 2021, 60 (09) : 1114 - 1121
12345